Fibrillar cleavage of muscles (FMS) is a pathological process that manifests itself in the form of splitting of muscle fibers into individual fibrils. This process can be associated with various diseases, such as muscular dystrophy, myopathy, Guillain-Barré syndrome, polymyositis, dermatomyositis and others.
Symptoms of PRM may include weakness, pain and fatigue in the muscles, as well as changes in their appearance. The muscle fibers may appear thinner or split into individual fibers.
Diagnosis of PRM is usually done using electromyography (EMG), which can detect changes in the electrical activity of muscles. Other testing methods, such as a muscle biopsy or magnetic resonance imaging (MRI), may also be used.
Treatment for PRM depends on the cause of the disease and may include medication, physical therapy, surgery, or other treatments. It is important to understand that PRM is a complex disease, and its treatment can take a long time and require a comprehensive approach.
Muscle fibrillation is a pathological condition in which muscle fibers cannot fully contract or, conversely, a muscle consists of many contracted muscle fibers, but is not able to fully perform its functions. The causes leading to fibrillary dystrophy are mainly associated with impaired neuromuscular interaction. This occurs due to problems with the functioning of the central nervous system (CNS), improper transmission of nerve impulses and reflexes to the body, or problems with blood circulation. In fact, with this pathology, the conductivity of muscle tissue is disrupted, which is why it does not contract or contractions become ineffective. Treatment for muscle fibrillation can take a long time, as it involves eliminating the source of the problem.